Clinical Trials

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07516704 2026-04-08

Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study

94 enrolled

Prostatic Neoplasms

NCT07515924 2026-04-07

Oral Gallium Maltolate for Recurrent Glioblastoma

8 enrolled

Glioblastoma

NCT07286318 2026-04-02

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT06828588 2026-03-30

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT07498439 2026-03-27

TILs Therapy for Multiple Primary Early-Stage NSCLC

50 enrolled

Thoracic

Primary Early-stage Non-small Cell Lung Cancer

NCT07498595 2026-03-27

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

CNSEndocrine

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

NCT07489625 2026-03-24

Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain

Cancer Pain

NCT07487402 2026-03-23

Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma

27 enrolled

Carcinoma, Hepatocellular

NCT07485049 2026-03-20

Phase 0/2 PD-Trigger Study of BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

78 enrolled

Glioblastoma

NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

Colorectal Cancer Metastatic

NCT07476027 2026-03-17

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07039760 2026-03-11

Asciminib With or Without Sildenafil for Brain Tumors

12 enrolled

Brain Neoplasms

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07458659 2026-03-09

CART-BCMA

3 enrolled

Multiple Myeloma

NCT07458919 2026-03-09

Therapy for Advanced NSCLC With EGFR 19delins Mutation

94 enrolled

Thoracic

Lung Neoplasms

NCT07429071 2026-03-04

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

70 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT07420036 2026-03-03

SFB6-ZN01 PET

98 enrolled

Hypersensitivity, Neoplasms

NCT07446257 2026-03-03

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

60 enrolled

Carcinoma, Hepatocellular

NCT07446686 2026-03-03

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

Breast

Breast Neoplasms

NCT07038278 2026-02-27

5-ALARMS

Sarcoma

NCT07210632 2026-02-27

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

38 enrolled

Brain Neoplasms, Glioma

NCT07318389 2026-02-27

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT07439120 2026-02-27

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Carcinoma, Transitional Cell

NCT07416682 2026-02-25

CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms

High-risk Plasma Cell Neoplasms

NCT07429721 2026-02-24

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.

24 enrolled

Multiple Myeloma

NCT05676489 2026-02-20

MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors

28 enrolled

Glioma

NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

24 enrolled

Cancer Pain, Opioid-Related Disorders, Neoplasms

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

GastrointestinalGynecologicOther solid neoplasmThoracic

24 enrolled

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT07319195 2026-02-18

WINIT-BC

32 enrolled

Breast

Breast Neoplasms

NCT07409766 2026-02-13

A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors

Advanced Malignant Tumors

NCT07392528 2026-02-11

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

15 enrolled

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica

NCT04016818 2026-02-10

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Breast

Breast Neoplasms

NCT07234721 2026-02-10

SL4903

9 enrolled

Multiple Myeloma, Recurrence

NCT07399444 2026-02-10

LB2505-0001

38 enrolled

Multiple Myeloma

NCT07396714 2026-02-09

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

88 enrolled

Warts

NCT07387666 2026-02-06

Imaging Acetadote Metabolism in Glioblastoma

Glioblastoma

NCT07394205 2026-02-06

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

18 enrolled

Pancreatic Neoplasms

NCT07389174 2026-02-05

Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

40 enrolled

mHSPC

NCT07389187 2026-02-05

Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

mCRPC

NCT07389525 2026-02-05

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

DermatologicGastrointestinalSarcoma

80 enrolled

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07384390 2026-02-04

TH-CAR-027 for Grade 4 Gliomas

21 enrolled

R/R Grade 4 Glioma

NCT07381582 2026-02-02

161Tb-LNC1011

15 enrolled

Prostatic Neoplasms

NCT06824363 2026-01-30

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

34 enrolled

Adenocarcinoma Of Esophagus

NCT07065552 2026-01-28

Tirzepatide in Obesity-Driven Endometrial Cancer

GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

NCT07362602 2026-01-23

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

Other hematologic neoplasm

47 enrolled

Hematologic Neoplasms

NCT07362732 2026-01-23

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection